A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations.
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005260:Female; D005333:Fetus / Q000187:drug effects; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D051379:Mice; D011247:Pregnancy; D013723:Teratogens; D014635:Valproic Acid / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity*
D001798:Blood Proteins; D013723:Teratogens; D014635:Valproic Acid